Hibernoma-like Changes and TFE3 Expression in Mesothelioma Mimicking TFE3-Translocation Renal Cell Carcinoma: A Diagnostic Pitfall.


Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
Sep 2021
Historique:
pubmed: 27 2 2021
medline: 4 1 2022
entrez: 26 2 2021
Statut: ppublish

Résumé

The long delay between asbestos exposure and the development of mesothelioma will likely result in an increased incidence of mesothelioma in our industrialized societies. Radiation therapy is another factor known to induce these tumors. We describe a rare case of foamy looking mesothelioma in a 63-year-old patient with a long oncology history of a supposed peritoneal carcinomatosis. The pathologist was faced with a diagnostic pitfall as this peritoneal clear cell tumor expressed transcription factor binding to immunoglobulin heavy constant mu enhancer 3 (TFE3) at the nuclear level. Fortunately, the pathologist performed an extensive panel of immunomarkers, leading to a final diagnosis of epithelioid mesothelioma. Thus, we describe the first case of mesothelioma expressing TFE3. Note that there was no rearrangement of TFE3 in fluorescence in situ hybridization.

Identifiants

pubmed: 33635114
doi: 10.1177/1066896921998000
doi:

Substances chimiques

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Biomarkers, Tumor 0
TFE3 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

627-630

Auteurs

Delphine Hoton (D)

Cliniques Universitaires Saint Luc, Brussels, Belgium.
IREC (Institut de Recherche Expérimentale et Clinique), UCL, Brussels, Belgium.

Mathieu Luyckx (M)

Cliniques Universitaires Saint Luc, Brussels, Belgium.

Christine Galant (C)

Cliniques Universitaires Saint Luc, Brussels, Belgium.
IREC (Institut de Recherche Expérimentale et Clinique), UCL, Brussels, Belgium.

Hélène Dano (H)

Cliniques Universitaires Saint Luc, Brussels, Belgium.
IREC (Institut de Recherche Expérimentale et Clinique), UCL, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH